Fever and Erythema in the Emergency Room

Seminars in Cutaneous Medicine and Surgery

Volumn 26, Issue 3, 2007, Pages 133-138

  Hughey, Lauren C ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

DRESS syndrome; erythroderma; fever; Kawasaki disease; Kawasaki disease like syndrome; recalcitrant erythematous desquamating disorder; RED disorder; staphylococcal scalded skin syndrome; toxic shock syndrome

Indexed keywords

ABACAVIR; ACETYLSALICYLIC ACID; ALLOPURINOL; ATAZANAVIR; AZATHIOPRINE; CARBAMAZEPINE; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DAPSONE; EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; FLUCONAZOLE; GOLD SALT; IBUPROFEN; IMMUNOGLOBULIN; MINOCYCLINE; NEVIRAPINE; OMEPRAZOLE; PHENOBARBITAL; PHENYTOIN; RITONAVIR; SULFADIAZINE SILVER; SULFONAMIDE; TERBINAFINE; VANCOMYCIN;

ADULT; ATOPIC DERMATITIS; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONSULTATION; CONTACT DERMATITIS; DIFFERENTIAL DIAGNOSIS; DRUG ERUPTION; EMERGENCY WARD; ERYTHEMA; FEVER; HUMAN; ICHTHYOSIS; LABORATORY DIAGNOSIS; LEUKEMIA; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PITYRIASIS RUBRA PILARIS; PRACTICE GUIDELINE; PSORIASIS; PUSTULOSIS PALMOPLANTARIS; REVIEW; SEBORRHEIC DERMATITIS; SEZARY SYNDROME; SKIN LYMPHOMA; SKIN MANIFESTATION; STAPHYLOCOCCUS; TOXIC EPIDERMAL NECROLYSIS; TOXIC SHOCK SYNDROME;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; DERMATITIS, EXFOLIATIVE; DIAGNOSIS, DIFFERENTIAL; EMERGENCY SERVICE, HOSPITAL; EPIDERMAL NECROLYSIS, TOXIC; FEVER; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; STAPHYLOCOCCAL SCALDED SKIN SYNDROME; SYNDROME;

EID: 36749098919     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2007.09.007     Document Type: Review

References (19)

1. Bachot N., and Roujeau J.C. Differential Diagnosis of Severe Cutaneous Drug Eruptions. Am J Clin Dermatol 4 (2003) 561-572
2. Bocquet H., Bagot M., and Roujeau J.C. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Arch Dermatol 134 (1998) 1108-1112
3. Shiohara T., Iijima M., Ikezawa Z., et al. The diagnosis of DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. (letter). Br J Dermatol 156 (2007) 1045-1092
4. Descamps V., Valance A., Edlinger C., et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 137 (2001) 301-304
5. Murray R.J. Recognition and management of Staphylococcus aureus toxin-mediated disease. Intern Med J 35 suppl (2005) S106-S119
6. Manders S.M. Toxin-mediated streptococcal and staphylococcal disease. J Am Acad Dermatol 39 (1998) 383-398
7. Patel G.K., and Finlay A.Y. Staphylococcal scalded skin syndrome: Diagnosis and management. Am J Clin Dermatol 4 (2003) 165-175
8. Dobson C.M., and King C.M. Adult Staphylococcal scalded skin syndrome: Histological pitfalls and new diagnostic perspectives. (letter). Br J Dermatol 148 (2003) 1058-1087
9. Edwards-Jones V., and Foster H.A. The effect of topical antimicrobial agents on the production of toxic shock syndrome toxin-1. J Med Microbiol 41 (1994) 408-413
10. Vergeront J.M., Stolz S.J., Crass B.A., et al. Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: Implications for toxic-shock syndrome. J Infect Dis 148 (1983) 598-692
11. Schlievert P.M., and Kelly J.A. Clindamycin-induced suppression of toxic-shock syndrome toxin-associated exotoxin production. J Infect Dis 149 (1984) 471
12. Cone L.A., Woodard D.R., Byrd R.G., et al. A Recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS. J Infect Dis 165 (1992) 638-643
13. Verbon A., and Fisher C.J. Severe recalcitrant erythematous desquamating disorder associated with fatal recurrent toxic shock syndrome in a patient without AIDS. Clin Infect Dis 24 (1997) 1274-1275
14. Dondorp A.M., Veenstra J., van der Poll T., et al. Activation of the cytokine network in a patient with AIDS and the recalcitrant erythematous desquamating disorder. Clin Infect Dis 18 (1994) 942-945
15. Seve P., Stankovik K., Durand D.V., et al. Adult Kawasaki disease: Report of two cases and literature review. Semin Arthritis Rheum 34 (2005) 785-792
16. Matsubara K., Fukaya T., Miwa K., et al. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease. Clin Exp Immunol 143 (2006) 427-434
17. Johnson R.M., Little J.R., and Storch G.A. Kawasaki-like syndromes associated with human immunodeficiency virus infection. Clin Infect Dis 32 (2001) 1628-1634
18. Blanchard J.N., Powell H.C., Freeman W.R., et al. Recurrent Kawasaki disease-like syndrome in a patient with acquired immunodeficiency syndrome. Clin Infect Dis 36 (2003) 105-111
19. Reingold A.L., Hargrett N.T., Shands K.N., et al. Toxic shock syndrome surveillance in the United States, 1980 to 1981. Ann Intern Med 96 part 2 (1982) 875-880